Special Issue "Advances in Breast Cancer Research and Treatment"
Deadline for manuscript submissions: 29 December 2023 | Viewed by 11664
Interests: breast cancer; bioinformatics; oncology
Interests: biophysics; single molecular assay; evolutionary genetics; molecular biology; genetics
Interests: autophagy; lysosomes; lysosomal cell death; apoptosis; anticancer drug resistance; breast cancer; hepatocellular carcinoma; protein turnover; molecular determinants of protein instability
Breast cancer is the most frequent malignancy worldwide. Recent developments in both clinical research and basic research have promoted our understanding and management of breast cancer.
This Special Issue on “Advances in Breast Cancer Research and Treatment” focuses on recent developments in clinical and basic research of breast cancer. We are pleased to invite you to submit research papers, reviews, communications, etc. for this Special Issue.
Research topics include, but are not limited to, biomarker identification, clinical pharmacology, histological and molecular subtypes, cancer genetics, medical imaging, progress in surgical and radiotherapy, and targeted therapy. Translational research and basic research are also welcome.
We look forward to receiving your contributions.
Dr. Taobo Hu
Dr. Mengping Long
Dr. Lei Wang
Dr. Riccardo Autelli
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- breast cancer
- clinical pharmacology
- translational research
- cancer biomarker
- targeted therapy
- medical imaging